Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Cash from Financing Activities (2016 - 2026)

United Therapeutics' Cash from Financing Activities history spans 17 years, with the latest figure at $98.4 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 231.73% to $98.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 billion, a 8.35% increase, with the full-year FY2025 number at -$1.2 billion, up 8.35% from a year prior.
  • Cash from Financing Activities hit $98.4 million in Q4 2025 for United Therapeutics, up from -$956.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for UTHR hit a ceiling of $98.4 million in Q4 2025 and a floor of -$1.1 billion in Q1 2024.
  • Historically, Cash from Financing Activities has averaged -$114.8 million across 5 years, with a median of $7.2 million in 2021.
  • Biggest five-year swings in Cash from Financing Activities: surged 640.0% in 2022 and later plummeted 2297.53% in 2024.
  • Tracing UTHR's Cash from Financing Activities over 5 years: stood at $7.5 million in 2021, then surged by 640.0% to $55.5 million in 2022, then tumbled by 267.21% to -$92.8 million in 2023, then rose by 19.5% to -$74.7 million in 2024, then skyrocketed by 231.73% to $98.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for UTHR at $98.4 million in Q4 2025, -$956.0 million in Q3 2025, and -$198.6 million in Q2 2025.